Diagnosis and Treatment of AL and ATTR Amyloidosis
Presented by Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®
From (1)Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio; (2)The University of Texas MD Anderson Cancer Center, Houston, Texas
J Adv Pract Oncol 2021;12(3):329–332 |
© 2021 Harborside™
At JADPRO Live Virtual 2020, Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN, and Tiffany Richards, PhD, ANP-BC, AOCNP®, differentiated between AL and ATTR amyloidosis, discussed key considerations in selecting therapy, and identified ways that advanced practitioners can manage the supportive care needs of this patient population.
For access to the full length article, please sign in